ADC Therapeutics SA (ADCT)

NYSE • Currently down 0.02 (-1.54%) in today's trading session

Track congressional stock trades in ADC Therapeutics SA (ADCT). Analyse trading activity from Nancy Pelosi and other members of Congress using public financial disclosure data.

ADC Therapeutics SA is currently trading at $1.28, positioned at 12% of its 52-week range ($0.78 – $4.98).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$1.28
24h Change
-0.02 (-1.54%)
52 Week Range
$0.78–$4.98
View on NASDAQ

ADC Therapeutics SA Price History and Technical Analysis

Congressional Trading Activity for ADCT

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$180.05M

Volume

1.1M

Beta

1.80

P/E Ratio

-1.94

Fundamentals

EPS

$-0.66

Div. Yield

-

Open

$1.27

Day Range

$1.26 – $1.35

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE · USD
Country
CH
CEO
Ameet Mallik
IPO Date
2020-05-18

ADC Therapeutics S.A. operates as a commercial-stage biotechnology company, focused on developing antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors. Its flagship product, ZYNLONTA, is presently being eva...

Earnings

Next Report

Q4 2026

9 Mar

EPS Est.

$-0.18

Rev. Est.

$22M

Days Until

107

Recent Quarters

Q3 20269 Nov
EPS$-0.16
Beat 24.7%
Q2 202613 Aug
EPS$-0.11
Beat 49.1%
Q1 20264 May
EPS$-0.21
Miss 10.5%
Q4 202510 Mar
EPS$-0.04
Beat 87.5%
Q3 202510 Nov
EPS$-0.30
Beat 25.0%
Q2 202512 Aug
EPS$-0.50
Miss 38.9%
Q1 202514 May
EPS$-0.36
Beat 5.3%
Q4 202427 Mar
EPS$-0.29
Beat 23.7%
Q3 20247 Nov
EPS$-0.42
Miss 16.7%
Q2 20246 Aug
EPS$-0.38
Beat 13.6%
Q1 20246 May
EPS$-0.56
Beat 0.0%
Q4 202313 Mar
EPS$-1.03
Miss 119.2%
Q3 20237 Nov
EPS$-0.58
Beat 4.9%
Q2 20238 Aug
EPS$-0.58
Miss 31.8%
Q1 20239 May
EPS$-0.74
Beat 7.5%
Q4 202228 Feb
EPS$-0.30
Beat 38.8%
Q3 20228 Nov
EPS$-0.65
Miss 84.2%
Q2 20229 Aug
EPS$-0.84
Beat 12.5%
Q1 20229 May
EPS$-0.22
Beat 67.3%
Q4 20213 Mar
EPS$-0.45
Beat 48.3%
Q3 20212 Nov
EPS$-0.93
Beat 4.1%
Q2 20213 Aug
EPS$-0.95
Miss 13.1%
Q1 20216 May
EPS$-0.67
Beat 26.0%
Q4 202018 Mar
EPS$-0.73
Miss 7.3%
Q3 202012 Nov
EPS$-0.58
Beat 24.7%
Q2 202018 Aug
EPS$-0.51
Beat 21.5%
Q4 20192 Mar
EPS$-0.68

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.